only with


Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Phar
Glaxosmithkline Pharmaceuticals Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap - With a market cap of ₹430.26 Cr.
| EX-Date | Purpose |
|---|---|
| 18 05 2021 | Dividend & Audited Results |
| 26 07 2021 | Quarterly Results |
| 29 10 2021 | Quarterly Results |
| 07 02 2022 | Quarterly Results |
| 16 05 2022 | Audited Results & Dividend |
| 25 07 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 07 02 2023 | Quarterly Results |
| 17 05 2023 | Final Dividend & Audited Results |
| 26 07 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 29 10 2024 | Interim Dividend & Quarterly Results |
| 10 02 2025 | Quarterly Results(Cancelled) (Cancelled) |
| 10 02 2025 | Quarterly Results |
| 14 02 2025 | Quarterly Results |
| 13 05 2025 | Final Dividend & Audited Results |
| 01 08 2025 | Quarterly Results |
| 06 11 2025 | Quarterly Results |
| 09 02 2026 | Quarterly Results |
| 13 05 2026 | Audited Results & Dividend |
| 03 08 2026 | Quarterly Results |
News
GlaxoSmithKline Pharmaceuticals informs about press release
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2533.30 Mln, in the June 2026 quarter
GlaxoSmithKline Pharmaceuticals informs about board meeting
GlaxoSmithKline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals informs about letter for weblink for annual report
GlaxoSmithKline Pharmaceuticals informs about secretarial compliance report
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2749.40 Mln, in the March 2026 quarter
GlaxoSmithKline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals informs about change in senior managerial personnel
GlaxoSmithKline Pharmaceuticals informs about updates
GlaxoSmithKline Pharmaceuticals informs about outcome of board meeting
GlaxoSmithKline Pharmaceuticals informs about disclosure
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2771.80 Mln, in the December 2025 quarter
GlaxoSmithKline Pharmaceuticals informs about analyst meet
GlaxoSmithKline Pharmaceuticals informs about closure of trading window
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2550.00 Mln, in the September 2025 quarter
Glaxosmithkline Pharmaceuticals trades marginally higher on the bourses
The company has forayed into India’s Oncology market
Glaxosmithkline Pharmaceuticals moves up on foraying into India’s Oncology market
The company has launched Jemperli (dostarlimab) and Zejula (niraparib) therapies
Glaxosmithkline Pharmaceuticals forays into India’s Oncology market
The company has launched Jemperli (dostarlimab) and Zejula (niraparib) therapies
GlaxoSmithKline Pharmaceuticals informs about press release
GlaxoSmithKline Pharmaceuticals informs about clarification
Glaxosmithkline Phar reports Profit after tax of Rs 2047.00 Mln, in the June 2025 quarter
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
GlaxoSmithKline Pharmaceuticals informs about analyst meet
GlaxoSmithKline Pharmaceuticals informs about analyst meet
GlaxoSmithKline Pharmaceuticals informs about analyst meet
GlaxoSmithKline Pharmaceuticals informs about transcript of analyst meetings
GlaxoSmithKline Pharmaceuticals informs about newspaper advertisements
GlaxoSmithKline Pharmaceuticals informs about secretarial compliance report
GlaxoSmithKline Pharmaceuticals submits analyst meet intimation
GlaxoSmithKline Pharmaceuticals informs about outcome of board meeting
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2601.40 Mln, in the March 2025 quarter
Glaxosmithkline Phar - Quaterly Results
GlaxoSmithKline Pharmaceuticals informs about increase in volumes
GlaxoSmithKline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals informs about newspaper advertisements
GlaxoSmithKline Pharmaceuticals informs about postal ballot notice
GlaxoSmithKline Pharmaceuticals informs about disclosure
Glaxosmithkline Pharmaceuticals informs about press release
Glaxosmithkline Pharmaceuticals informs about analyst meet
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2285.80 Mln, in the December 2024 quarter
Glaxosmithkline Pharmaceuticals informs about analyst meet
Glaxosmithkline Pharmaceuticals informs about disclosure
Glaxosmithkline Pharmaceuticals informs about board meeting
GlaxoSmithKline Pharmaceutical informs about change in directorate
Glaxosmithkline Pharmaceuticals informs about receipt of order
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2486.90 Mln, in the September 2024 quarter
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Pharmaceuticals informs about loss of share certificate
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
GlaxoSmithKline Pharmaceuticals informs about certificate
Glaxosmithkline Pharmaceuticals informs about compliances-certificate
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about issue of duplicate share certificates
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about analyst meet
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about press release
Glaxosmithkline Phar reports Profit after tax of Rs 454.90 Mln, in the December 2023 quarter
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
GlaxoSmithKline Pharmaceuticals rises on establishing Omnichannel Team
The company has also completed the VRS and spent a sum of Rs 156.57 crore as the one-off cost of the VRS
GlaxoSmithKline Pharmaceuticals establishes Omnichannel Team to expand reach
The company has also completed the VRS and spent a sum of Rs 156.57 crore as the one-off cost of the VRS
Glaxosmithkline Pharmaceuticals informs about resignation of senior managerial personnel
Glaxosmithkline Pharmaceuticals informs about disclosure
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 2155.40 Mln, in the September 2023 quarter
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about disclosure
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
GlaxoSmithKline Pharmaceuticals informs about ODR portal
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
Glaxosmithkline Pharmaceuticals informs about issue of duplicate share certificates
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 1305.80 Mln, in the June 2023 quarter
GlaxoSmithKline Pharmaceutical informs about newspaper advertisement
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar reports Profit after tax of Rs 1314.80 Mln, in the March 2023 quarter
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate
GlaxoSmithKline Pharmaceuticals informs about institutional investors meeting
Glaxosmithkline Pharmaceuticals informs about details of loss of certificate
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
GlaxoSmithKline Pharmaceuticals informs about closure of trading window
Glaxosmithkline Pharmaceuticals informs about updates
Glaxosmithkline Pharmaceuticals informs about postal ballot notice
GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates
Glaxosmithkline Phar reports Profit after tax of Rs 1935.60 Mln, in the September 2022 quarter
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Phar - Quaterly Results
Glaxosmithkline Pharma trades in green on the BSE
LIC had offloaded 34.63 lakh equity shares or 2.04 percent stake in Glaxosmithkline Pharmaceuticals via open market transactions
LIC sells 2.04% stake in Glaxosmithkline Pharma
With this, LIC’s shareholding in the company reduced to 4.35 percent

